What stable producer cell lines unlock for rAAV manufacturing.
One-Time Cell Line Creation
All plasmid DNA is integrated into the host cell genome, eliminating the need for repeated plasmid manufacturing costs for every batch.
Built-In Consistency
Stable genomic integration of AAV components creates a fixed, heritable production platform — eliminating transient transfection variability and enabling the high reproducibility that GMP compliance and commercial-scale manufacturing demands.
Scalable Manufacturing
Stable producer cell lines enable seamless scale-up and tech transfer, accelerating efficient and reliable clinical and commercial manufacturing.
Reduced Manufacturing Burden
Reduced raw materials, streamlined process steps, and lower batch variability simplify manufacturing and significantly reduce the cost of goods sold (COGS).
process
Transition from Transient to Stable rAAV Production
A Fully Characterized Cell Line Pedigree Enabling Seamless Development from Early Research to Commercial Manufacturing.
End-to-end support for R&D and CMC readiness
Genome stability & praticity control
Transcriptomics & epigenomics
Clonality
Transgene integrity
Integration sites
Safety
QA / QC
Timeline
From Transfection to Transfer-Ready RCB in just 16 Weeks!
